Theriva Biologics, Inc. SEC filings TOVX

Theriva Biologics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 25, 1998. Its latest annual report, Form ARS, was filed on Jun 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jun 29, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Jul 9, 2025 Dec 31, 2024
10-K Annual report Mar 6, 2025 Dec 31, 2024
ARS Annual report to shareholders Oct 1, 2024 Dec 31, 2023
10-K Annual report Mar 25, 2024 Dec 31, 2023
ARS Annual report to shareholders Aug 15, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 16, 2022 Dec 31, 2021
10-K Annual report Mar 4, 2021 Dec 31, 2020
10-K Annual report Feb 20, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Feb 27, 2019 Dec 31, 2018
10-K Annual report Feb 22, 2018 Dec 31, 2017
10-K Annual report Mar 2, 2017 Dec 31, 2016
10-K Annual report Mar 10, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2014 Dec 31, 2013
10-K Annual report Apr 16, 2013 Dec 31, 2012
10-K/A Amended annual report May 11, 2012 Dec 31, 2011
10-K Annual report Mar 30, 2012 Dec 31, 2011
10-K Annual report Mar 31, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2009 Dec 31, 2008
10-K Annual report Mar 31, 2008 Dec 31, 2007
ARS Annual report to shareholders Oct 30, 2007 Dec 31, 2006
10-K Annual report Apr 15, 2003 Dec 31, 2002
10-K Annual report Mar 29, 2000 Dec 31, 1999
10-K Annual report Mar 24, 1999 Dec 31, 1998

Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TOVX (NYSE)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Rockville, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
894158
Former names
Synthetic Biologics, Inc. (until Oct 12, 2022); ADEONA PHARMACEUTICALS, INC. (until Feb 17, 2012); PIPEX PHARMACEUTICALS, INC. (until Oct 16, 2008); SHEFFIELD PHARMACEUTICALS INC (until Dec 8, 2006); SHEFFIELD MEDICAL TECHNOLOGIES INC (until May 14, 1997)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.